-
1
-
-
2142743257
-
The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers
-
10.1245/ASO.2004.03.012
-
I Pappo I Meirshon T Karni, et al. 2003 The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers Ann Surg Oncol 11 52 8 10.1245/ASO.2004.03.012
-
(2003)
Ann Surg Oncol
, vol.11
, pp. 52-8
-
-
Pappo, I.1
Meirshon, I.2
Karni, T.3
-
2
-
-
0030843969
-
Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
-
DOI 10.1016/S0140-6736(97)08233-0
-
Collaborative Group on Hormone Factors for Breast Cancer 1997 Breast cancer and hormone replacement therapy: collaborative reanalysis from 51 individual epidemiological studies Lancet 350 1047 60 10.1016/S0140-6736(97) 08233-0 (Pubitemid 27437855)
-
(1997)
Lancet
, vol.350
, Issue.9084
, pp. 1047-1059
-
-
Beral, V.1
-
3
-
-
0031717805
-
Low biologic aggressiveness in breast cancer in women using hormone replacement therapy
-
9738583 1:CAS:528:DyaK1cXmtFSlsLc%3D
-
K Holli J Isola J Cuzik 1998 Low biologic aggressiveness in breast cancer in women using hormone replacement therapy J Clin Oncol 16 3115 20 9738583 1:CAS:528:DyaK1cXmtFSlsLc%3D
-
(1998)
J Clin Oncol
, vol.16
, pp. 3115-20
-
-
Holli, K.1
Isola, J.2
Cuzik, J.3
-
4
-
-
0029056755
-
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
-
7753136 1:STN:280:ByqB2s3msVQ%3D 10.1056/NEJM199506153322401
-
GA Colditz SE Hankinson DJ Hunter, et al. 1995 The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1589 93 7753136 1:STN:280:ByqB2s3msVQ%3D 10.1056/NEJM199506153322401
-
(1995)
N Engl J Med
, vol.332
, pp. 1589-93
-
-
Colditz, G.A.1
Hankinson, S.E.2
Hunter, D.J.3
-
5
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women
-
Writing Group for the Women's Health Initiative Investigators. 10.1001/jama.288.3.321
-
Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women JAMA 288 321 33 10.1001/jama.288.3.321
-
(2002)
JAMA
, vol.288
, pp. 321-33
-
-
-
6
-
-
0032911246
-
Estrogen replacement therapy and breast cancer: Analysis of age of onset and tumor characteristics
-
10082047 1:STN:280:DyaK1M7otVSrtg%3D%3D 10.1007/s10434-999-0200-7
-
MM Bilimoria DJ Winchester SF Sener G Motykie UL Sehgal DP Winchester 1999 Estrogen replacement therapy and breast cancer: analysis of age of onset and tumor characteristics Ann Surg Oncol 6 200 7 10082047 1:STN:280: DyaK1M7otVSrtg%3D%3D 10.1007/s10434-999-0200-7
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 200-7
-
-
Bilimoria, M.M.1
Winchester, D.J.2
Sener, S.F.3
Motykie, G.4
Sehgal, U.L.5
Winchester, D.P.6
-
7
-
-
0036778134
-
Tamoxifen: An update on current data and where it can now be used
-
10.1023/A:1020353530963
-
L Wickerham 2002 Tamoxifen: an update on current data and where it can now be used Breast Cancer Res Treat 75 Suppl 1 7 12 10.1023/A:1020353530963
-
(2002)
Breast Cancer Res Treat
, vol.75
, Issue.SUPPL. 1
, pp. 7-12
-
-
Wickerham, L.1
-
8
-
-
0036219284
-
Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users
-
DOI 10.1245/aso.2002.9.3.266
-
V Sacchini S Zurrida G Andreoni, et al. 2002 Pathologic and biologic prognostic factors of breast cancers in short- and long-term hormone replacement therapy users Ann Surg Oncol 9 266 71 11923133 10.1245/aso.2002.9.3.266 (Pubitemid 34298631)
-
(2002)
Annals of Surgical Oncology
, vol.9
, Issue.3
, pp. 266-271
-
-
Sacchini, V.1
Zurrida, S.2
Andreoni, G.3
Luini, A.4
Galimberti, V.5
Veronesi, P.6
Intra, M.7
Viale, G.8
Veronesi, U.9
|